According to Illumina's latest financial reports the company's current EPS (TTM) is -$26.61. In 2022 the company made an earnings per share (EPS) of -$28.00 a decrease over its 2021 EPS that were of $5.09.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$26.61 | -4.96% |
2022 | -$28.00 | -650.1% |
2021 | $5.09 | 13.62% |
2020 | $4.48 | -34.21% |
2019 | $6.81 | 21.17% |
2018 | $5.62 | 13.31% |
2017 | $4.96 | 56.96% |
2016 | $3.16 | -0.94% |
2015 | $3.19 | 24.12% |
2014 | $2.57 | 157% |
2013 | $1.00 | -18.03% |
2012 | $1.22 | 71.83% |
2011 | $0.71 | -29.7% |
2010 | $1.01 | 71.19% |
2009 | $0.59 | 71.01% |
2008 | $0.34 | -113.29% |
2007 | -$2.60 | -684.79% |
2006 | $0.44 | -274.02% |
2005 | -$0.26 | 200% |
2004 | -$0.08500 | -80% |
2003 | -$0.43 | -35.11% |
2002 | -$0.66 | 57.83% |
2001 | -$0.42 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $15.34 | -157.65% | ๐บ๐ธ USA |
![]() Agilent Technologies A | $3.83 | -114.39% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $6.76 | -125.40% | ๐บ๐ธ USA |
![]() Danaher DHR | $8.02 | -130.14% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $7.70 | -128.94% | ๐บ๐ธ USA |
![]() Pacific Biosciences
PACB | -$1.27 | -95.23% | ๐บ๐ธ USA |